BUZZ-Resmed's Australia shares fall; Macquarie hikes PT

Healthcare technology co Resmed's Australia-listed shares RMD.AX fall 2.7% to A$39.105, on track for worst session since Oct. 29, 2024 - if current losses hold

Stock tracks a sell-off in broader market .AXJO, which is down 1.7% .AX

Meanwhile, Macquarie hikes PT to A$45.10 from A$41.10, signalling a 9.7% upside potential

PT hike reflects 1% increase in earnings forecasts for FY25 and 26, driven by foreign exchange and buyback assumptions adjustments, among others

Nine of 11 analysts rate the stock "buy" or higher, and two "hold"; their median PT is A$43.80 – LSEG data

Stock rose 44.5% in 2024